An improved and commercial viable process for the active pharmaceutical ingredient of new Long-acting β2- adrenergic agonist (LABA) Salmeterol has been developed. This improved process includes the isolation of Salmeterol 1 and identification, controlling and synthesis of its potential Diether impurity 2.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report